The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Open accessAbstract
Background: From December 2019 to February 2020, 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a serious outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China. Related clinical features are needed. Methods: We reviewed 69 patients who were hospitalized in Union hospital in Wuhan between 16 January and 29 January 2020. All patients were confirmed to be infected with SARS-CoV-2, and the final date of follow-up was 4 February 2020. Results: The median age of 69 enrolled patients was 42.0 years (interquartile range 35.0–62.0), and 32 patients (46%) were men. The most common symptoms were fever (60 [87%]), cough (38 [55%]), and fatigue (29 [42%]). Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). As of 4 February 2020, 18 (26.9%) of 67 patients had been discharged, and 5 patients had died, with a mortality rate of 7.5%. According to the lowest SpO2 during admission, cases were divided into the SpO2 ≥ 90% group (n = 55) and the SpO2 < 90% group (n = 14). All 5 deaths occurred in the SpO2 < 90% group. Compared with SpO2 ≥ 90% group, patients of the SpO2 < 90% group were older and showed more comorbidities and higher plasma levels of interleukin (IL) 6, IL10, lactate dehydrogenase, and C reactive protein. Arbidol treatment showed tendency to improve the discharging rate and decrease the mortality rate. Conclusions: COVID-19 appears to show frequent fever, dry cough, and increase of inflammatory cytokines, and induced a mortality rate of 7.5%. Older patients or those with underlying comorbidities are at higher risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients infected with SARS-CoV-2 present elevated levels of IL-6, IL-10, IL-1β, INF-γ, CCL2, TNF-α, CXCL10, CCL7, IL-1 receptor antagonist and IL-2 receptor, supposedly associated with disease severity [9, 98–105].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [105]
In the citing paper
“The authors provide a detailed description of major signs and symptoms of overt disease [2, 3], but fail to give an account of minor symptoms that may be present at earlier stages of the infection.”
From Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study (2020) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Self-citationLu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationChan, J., Yuan, S.-F., Kok, K.-H., To, K., Chu, H., Yang, J., Xing, F., Liu, J.-L., Yip, C., Poon, R., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,450
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Wu, J. T., Leung, K., & Leung, G. M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30260-9 · Cited by 4,389
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N. L. S., Hui, D. S. C., Wu, A. K. L., Chan, P. K. S., Cameron, P. A., Joynt, G. M., Ahuja, A. T., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,638
Flagged first, then by citations
Research works printed but not linked: 2
- National Health Commission of China, Guideline of management of COVID-19 (version 3)
- National Health Commission of China, Guideline of management of COVID-19 (version 7)
Cited by
Sorted by citations
Items 201–300 of 1,001
Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID‐19 patients
Erdoğan, A., Can, F. E., & Gönüllü, H. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27097 · Cited by 82
Darbani, B. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103433 · Cited by 81
COVID‐19 and liver dysfunction: A systematic review and meta‐analysis of retrospective studies
Youssef, M. R., Hussein, M. H., Attia, A. S., Elshazli, R. M., Omar, M., Zora, G., Farhoud, A. S., Elnahla, A., Shihabi, A., Toraih, E. A., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26055 · Cited by 81
A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
Zhou, H., Yang, J., Zhou, C. S., Chen, B., Fang, H., Chen, S., Zhang, X., Wang, L., & Zhang, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.628370 · Cited by 87
Pourajam, S., Kalantari, E., Talebzadeh, H., Melali, H., Sami, R., Soltaninejad, F., Amra, B., Sajadi, M., Alenaseri, M., Kalantari, F., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.784130 · Cited by 82
Alhumaid, S., Mutair, A. S. A., Alawi, Z. A., Alshawi, A. M., Alomran, S. A., Almuhanna, M. S., Almuslim, A. A., Shafia, A. H. B., Alotaibi, A. F., Ahmed, G. Y., et al. (2021) · Pathogens · doi:10.3390/pathogens10070809 · Cited by 78
Case fatality rate in COVID-19: a systematic review and meta-analysisPreprint
Kahathuduwa, C. N., Dhanasekara, C. S., & Chin, S.-H. (2020) · medRxiv · doi:10.1101/2020.04.01.20050476 · Cited by 83
Tsuchiya, A., Takeuchi, S., Iwasawa, T., Kumagai, M., Sato, T., Motegi, S., Ishii, Y., Koseki, Y., Tomiyoshi, K., Natsui, K., et al. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00121-y · Cited by 79
Chauhan, D. S., Prasad, R., Srivastava, R., Jaggi, M., Chauhan, S. C., & Yallapu, M. M. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00323 · Cited by 81
Gorji, A., & Ghadiri, M. K. (2020) · Nutrition · doi:10.1016/j.nut.2020.111047 · Cited by 85
Neurological Manifestations in COVID-19 Patients: A Meta-Analysis
Vitalakumar, D., Sharma, A., Kumar, A., & Flora, S. J. S. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00353 · Cited by 83
Advances in the relationship between coronavirus infection and cardiovascular diseases
Zhao, M., Wang, M., Zhang, J., Ye, J., Xu, Y. Q., Wang, Z., Ye, D., Liu, J., & Wan, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110230 · Cited by 83
Self-citationPrevalence of Anosmia and Ageusia in Patients with COVID-19 at a Primary Health Center, Doha, Qatar
Al-Ani, R. M., & Acharya, D. (2020) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-020-02064-9 · Cited by 78
COVID-19 Therapeutic Options Under Investigation
Kaddoura, M., Ibrahim, M. A., Hijazi, G., Soudani, N., Audi, A., Alkalamouni, H., Haddad, S., Eid, A. H., & Zaraket, H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01196 · Cited by 75
Cagnazzo, F., Arquizan, C., Derraz, I., Dargazanli, C., Lefèvre, P.-H., Riquelme, C., Gaillard, N., Mourand, I., Gascou, G., Bonafé, A., et al. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10285-9 · Cited by 73
Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review
Lingeswaran, M., Goyal, T., Ghosh, R., Suri, S., Mitra, P., Misra, S., & Sharma, P. (2020) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-020-00897-3 · Cited by 78
Tripathy, S., Verma, D. K., Thakur, M., Patel, A. R., Srivastav, P. P., Sıngh, S., Gupta, A. K., Chávez‐González, M. L., Aguilar, C. N., Chakravorty, N., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.747956 · Cited by 81
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients
Paolisso, P., Bergamaschi, L., D’Angelo, E. C., Donati, F., Giannella, M., Tedeschi, S., Pascale, R., Bartoletti, M., Tesini, G., Biffi, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01124 · Cited by 72
Burian, E., Jungmann, F., Kaissis, G. A., Lohöfer, F. K., Spinner, C. D., Lahmer, T., Treiber, M., Dommasch, M., Schneider, G. H., Geisler, F., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051514 · Cited by 71
Nardo, P. D., Gentilotti, E., Mazzaferri, F., Cremonini, E., Hansen, P., Goossens, H., Tacconelli, E., Durante‐Mangoni, E., Florio, L. L., Zampino, R., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.082 · Cited by 74
Ibarguren, A. M., Busca, C., & Robles‐Marhuenda, Á. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01736 · Cited by 72
Saniasiaya, J., & Kulasegarah, J. (2020) · Ear Nose & Throat Journal · doi:10.1177/0145561320959573 · Cited by 71
Patel, U. K., Malik, P., Mehta, D., Shah, D., Kelkar, R., Pinto, C., Suprun, M., Dhamoon, M. S., Hennig, N., & Sacks, H. S. (2020) · Journal of Global Health · doi:10.7189/jogh.10.020506 · Cited by 70
Multiple sclerosis and COVID‐19: How many are at risk?
Bsteh, G., Bitschnau, C., Hegen, H., Auer, M., Pauli, F. D., Rommer, P. S., Deisenhammer, F., & Berger, T. (2020) · European Journal of Neurology · doi:10.1111/ene.14555 · Cited by 74
Aktaş, G. (2020) · Experimental Biomedical Research · doi:10.30714/j-ebr.2020463629 · Cited by 72
Elshazli, R. M., Kline, A., Elgaml, A., Aboutaleb, M. H., Salim, M. M., Omar, M., Munshi, R., Mankowski, N. L., Hussein, M. H., Attia, A. S., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26836 · Cited by 67
Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
Estrada, A. D. B., Calderón‐Parra, J., Carracedo, E. F., Míguez, A. M., Ramos, A., Múñez, E., Rubio‐Rivas, M., de Blas, P. A., Arnalich, F., Pérez, V. E., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06821-1 · Cited by 73
Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N. K., Singla, V., Khare, S., & Srivastava, A. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3566166 · Cited by 69
Cena, H., & Chieppa, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00944 · Cited by 72
A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
Neerukonda, S. N., & Katneni, U. (2020) · Pathogens · doi:10.3390/pathogens9060426 · Cited by 70
Saini, V., Jain, C. M., Singh, N. P., Alsulimani, A., Gupta, C., Dar, S. A., Haque, S., & Das, S. (2021) · Antibiotics · doi:10.3390/antibiotics10080954 · Cited by 69
Roberts, J., Pritchard, A. L., Treweeke, A. T., Rossi, A. G., Brace, N., Cahill, P. A., MacRury, S. M., Wei, J., & Megson, I. L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.629933 · Cited by 68
Ischemic Stroke Occurs Less Frequently in Patients With COVID-19
Bekelis, K., Missios, S., Ahmad, J., Labropoulos, N., Schirmer, C. M., Calnan, D. R., Skinner, J., & MacKenzie, T. A. (2020) · Stroke · doi:10.1161/strokeaha.120.031217 · Cited by 66
Blasco, M. L., Buesa, J., Colomina, J., Forner, M. J., Galindo, M. J., Navarro, J., Noceda, J., Redón, J., Signes‐Costa, J., & Navarro, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25922 · Cited by 66
COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature
Lorenzo, G. D., Trolio, R. D., Kozlakidis, Z., Busto, G., Ingenito, C., Buonerba, L., Ferrara, C., Libroia, A., Ragone, G., Ioio, C. D., et al. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102991 · Cited by 66
Wei, Y., Zeng, W., Huang, X., Li, J., Qiu, X., Li, H., Liu, D., He, Z., Yao, W., Huang, P. C., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05252-8 · Cited by 66
A systematic review and meta-analysis of the COVID-19 associated liver injury
Wong, Y. J., Tan, M. T. K., Zheng, Q., Li, J. W., Kumar, R., Fock, K. M., Teo, E. K., & Ang, T. L. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.08.064 · Cited by 66
Pouladzadeh, M., Safdarian, M., Eshghi, P., Abolghasemi, H., bavani, A. G., Sheibani, B., Choghakabodi, P. M., Feghhi, A., Boroujerdnia, M. G., Forouzan, A., et al. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-021-02734-8 · Cited by 66
Aggarwal, G., Lippi, G., Lavie, C. J., Henry, B. M., & Sanchis‐Gomar, F. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13091 · Cited by 78
Yan, L., Mir, M., Sanchez, P., Beg, M., Peters, J. I., Enriquez, O., & Gilbert, A. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0217-sa · Cited by 66
An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics
Wang, D., Li, Z., & Liu, Y. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.004 · Cited by 65
Suručić, R. V., Tubić, B., Stojiljković, M. P., Djuric, D. M., Travar, M., Grabež, M., Šavikin, K., & Škrbić, R. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03981-7 · Cited by 65
Welcome, M. O., & Mastorakis, N. E. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00806-x · Cited by 66
Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19
Schmulson, M. J., Dávalos, M. F., & Berumen-Campos, J. (2020) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2020.04.001 · Cited by 65
Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19
Rahman, M. T. (2020) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2020.100382 · Cited by 65
Exploring the Potential of Carbon Dots to Combat COVID-19
Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Alhakamy, N. A., Md, S., Nair, A. B., & Deb, P. K. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.616575 · Cited by 66
Ascierto, P. A., Fox, B. A., Urba, W. J., Anderson, A. C., Atkins, M. B., Borden, E. C., Brahmer, J. R., Butterfield, L. H., Cesano, A., Chen, D. S., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000878 · Cited by 61
Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients
Tabibi, S., Tabibi, T., Conic, R. R. Z., Banisaeed, N., & Streiff, M. B. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620940259 · Cited by 64
Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
Gellings, P. S., Wilkins, A. A., & Morici, L. A. (2020) · Pathogens · doi:10.3390/pathogens9121066 · Cited by 62
Surveillance of Antibacterial Usage during the COVID-19 Pandemic in England, 2020
Andrews, A., Budd, E. L., Hendrick, A., Ashiru-Oredope, D. A. I., Beech, E., Hopkins, S., Gerver, S. M., Müller‐Pebody, B., & the AMU COVID-19 Stakeholder Group (2021) · Antibiotics · doi:10.3390/antibiotics10070841 · Cited by 65
The role of immune activation and antigen persistence in acute and long COVID
Opsteen, S., Files, J. K., Fram, T., & Erdmann, N. B. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231158041 · Cited by 65
Lapić, I., Rogić, D., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0620 · Cited by 65
A novel simple scoring model for predicting severity of patients with SARS‐CoV‐2 infection
Dong, Y., Zhou, H., Li, M., Zhang, Z., Guo, W., Yu, T., Yang, G., Wang, Q., Zhao, L., Luo, S., et al. (2020) · Transboundary and Emerging Diseases · doi:10.1111/tbed.13651 · Cited by 62
An Evaluation of Biometric Monitoring Technologies for Vital Signs in the Era of COVID‐19
Manta, C. J., Jain, S. S., Coravos, A., Mendelsohn, D., & Izmailova, E. S. (2020) · Clinical and Translational Science · doi:10.1111/cts.12874 · Cited by 65
Does SARS-CoV-2 Trigger Stress-Induced Autoimmunity by Molecular Mimicry? A Hypothesis
Cappello, F., Marino, A., Dieli, F., de Macario, E. C., & Macario, A. J. L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072038 · Cited by 60
Bragazzi, N. L., Riccò, M., Pacifico, A., Malagoli, P., Kridin, K., Pigatto, P. D. M., & Damiani, G. B. (2020) · Dermatologic Therapy · doi:10.1111/dth.13508 · Cited by 59
Almerie, M. Q., & Kerrigan, D. D. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109883 · Cited by 60
Eosinophil Response Against Classical and Emerging Respiratory Viruses: COVID-19
Rodrigo-Muñoz, J. M., Sastre, B., Cañas, J. A., Gil‐Martínez, M., Redondo, N., & del Pozo, V. (2020) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0624 · Cited by 59
Yang, H., & Lu, S. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0010 · Cited by 58
SARS-CoV-2: Targeted managements and vaccine development
Bakhiet, M., & Taurin, S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.11.001 · Cited by 65
Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19
Durán-Manuel, E. M., Cruz-Cruz, C., Ibáñez-Cervantes, G., Bravata-Alcántara, J. C., Sosa-Hernández, Ó., Delgado–Balbuena, L., León-García, G., Cortés-Ortíz, I. A., Cureño-Díaz, M. A., Castro‐Escarpulli, G., et al. (2021) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.13545 · Cited by 59
Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19
Jin, B., Singh, R., Ha, S. E., Zogg, H., Park, P. J., & Ro, S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i19.2341 · Cited by 59
Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19)
Lippi, G., Wong, J., & Henry, B. M. (2020) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2020.03.013 · Cited by 57
Lippi, G., de Oliveira, M. H. S., & Henry, B. M. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001742 · Cited by 56
Convertino, I., Tuccori, M., Ferraro, S., Valdiserra, G., Cappello, E., Focosi, D., & Blandizzi, C. (2020) · Critical Care · doi:10.1186/s13054-020-03020-3 · Cited by 55
Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N. K., Singla, V., Khare, S., & Srivastava, A. (2020) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01058-3 · Cited by 55
Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?
Zahra, S. A., Iddawela, S., Pillai, K., Choudhury, R. Y., & Harky, A. (2020) · Brain and Behavior · doi:10.1002/brb3.1839 · Cited by 62
Khinda, J., Janjua, N. Z., Cheng, S. S. Y., van den Heuvel, E. R., Bhatti, P., & Darvishian, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26411 · Cited by 53
Li, J., Liao, X., Zhou, Y., Wang, L., Yang, H., Zhang, W., Zhang, Z., & Kang, Y. (2021) · Shock · doi:10.1097/shk.0000000000001738 · Cited by 55
The common risk factors for progression and mortality in COVID-19 patients: a meta-analysis
Zhang, L., Hou, J., Ma, F.-Z., Li, J., Xue, S., & Xu, Z. (2021) · Archives of Virology · doi:10.1007/s00705-021-05012-2 · Cited by 55
Hu, H., Pan, H., Li, R., He, K., Zhang, H., & Liu, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.802228 · Cited by 54
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19
Schmulson, M. J., Dávalos, M. F., & Berumen-Campos, J. (2020) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2020.04.001 · Cited by 56
Parohan, M., Yaghoubi, S., & Seraji, A. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872620937165 · Cited by 53
Rabbani, G. H., Islam, S. M. S., Rahman, M. A., Amin, N., Marzan, B., Robin, R. C., & Alif, S. M. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1866547 · Cited by 55
Lymphopenia: A useful predictor of COVID-19 disease severity and mortality
Toori, K. U., Qureshi, M. A., & Chaudhry, A. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.7.4085 · Cited by 53
Corticosteroids for COVID-19: worth it or not?
Akter, F., Araf, Y., & Hosen, M. J. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06793-0 · Cited by 53
Asadirad, A., Nashibi, R., Khodadadi, A., Ghadiri, A., Sadeghi, M., Aminian, A., & Dehnavi, S. (2022) · Phytotherapy Research · doi:10.1002/ptr.7375 · Cited by 54
Effects of SARS‐CoV‐2 infection on male sex‐related hormones in recovering patients
Xu, H., Wang, Z., Feng, C., Yu, W., Chen, Y., Zeng, X., & Liu, C. (2020) · Andrology · doi:10.1111/andr.12942 · Cited by 53
Self-citationZekavat, S. M., Honigberg, M. C., Pirruccello, J. P., Kohli, P., Karlson, E. W., Newton‐Cheh, C., Zhao, H., & Natarajan, P. (2020) · Med · doi:10.1016/j.medj.2020.11.001 · Cited by 55
Early prediction of COVID‐19 severity using extracellular vesicle COPB2
Fujita, Y., Hoshina, T., Matsuzaki, J., Yoshioka, Y., Kadota, T., Hosaka, Y., Fujimoto, S., Kawamoto, H., Watanabe, N., Sawaki, K., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12092 · Cited by 56
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review
Fajgenbaum, D. C., Khor, J. S., Gorzewski, A., Tamakloe, M.-A., Powers, V., Kakkis, J. J., Repasky, M., Taylor, A., Beschloss, A., Hernandez-Miyares, L., et al. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00303-8 · Cited by 52
IL-6 modulation for COVID-19: the right patients at the right time?
Ascierto, P. A., Fu, B., & Wei, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002285 · Cited by 50
Cultrera, R., Barozzi, A., Libanore, M., Marangoni, E., Pora, R., Quarta, B., Spadaro, S., Ragazzi, R., Marra, A. R., Segala, D., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084358 · Cited by 50
Sañudo, B., Seixas, A., Gloeckl, R., Rittweger, J., Rawer, R., Taïar, R., van der Zee, E. A., van Heuvelen, M. J. G., Lacerda, A. C. R., Sartório, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103650 · Cited by 53
Mahumud, R. A., Kamara, J. K., & Renzaho, A. M. N. (2020) · Infection · doi:10.1007/s15010-020-01502-8 · Cited by 50
Zhu, Y., Zhang, J., Li, Y., Liu, F., Zhou, Q., & Peng, Z. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248671 · Cited by 52
Fungal co-infection in COVID-19 patients: evidence from a systematic review and meta-analysis
Peng, J., Wang, Q., Mei, H., Zheng, H., Liang, G., She, X., & Liu, W. (2021) · Aging · doi:10.18632/aging.202742 · Cited by 52
Zhao, R., Su, Z., Komissarov, A. A., Liu, S., Yi, G., Idell, S., Matthay, M. A., & Ji, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691249 · Cited by 50
Bahçe, Y. G., Acer, Ö., & Özüdoğru, O. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105409 · Cited by 52
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy
Lenti, M. V., de Andreis, F. B., Pellegrino, I., Klersy, C., Merli, S., Miceli, E., Aronico, N., Mengoli, C., Stefano, M. D., Cococcia, S., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02425-w · Cited by 49
Current Understanding of COVID-19 Clinical Course and Investigational Treatments
Aguilar, R. B., Hardigan, P. C., Mayi, B. S., Sider, D., Piotrkowski, J., Mehta, J. P., Dev, J., Armas, Y. S. D., Camargo, A. L., Andux, L., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.555301 · Cited by 49
Martens, R. J. H., van Adrichem, A. J., Mattheij, N. J. A., Brouwer, C. G., van Twist, D. J. L., Broerse, J. J. C. R., Checa, C. M., van Dongen, C. M. P., Mostard, R. L. M., Ramiro, S., et al. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1529 · Cited by 49
A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, ChinaPreprint
Zhou, Y., Yang, Z. Y., Guo, Y., Geng, S., Gao, S., Ye, S., Hu, Y., & Wang, Y. (2020) · medRxiv · doi:10.1101/2020.03.24.20042119 · Cited by 49
Kim, D. W., Byeon, K. H., Kim, J., Cho, K., & Lee, N. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e243 · Cited by 47
Xia, S., Wu, M. T., Chen, S., Zhang, T., Ye, L., Liu, J., & Li, H. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00253-y · Cited by 49
Gatti, M., Calandri, M., Barba, M., Biondo, A., Geninatti, C., Gentile, S., Greco, M., Morrone, V., Piatti, C., Santonocito, A., et al. (2020) · La radiologia medica · doi:10.1007/s11547-020-01272-1 · Cited by 47
Flook, M., Jackson, C., Vasileiou, E., Simpson, C. R., Muckian, M. D., Agrawal, U., McCowan, C., Jia, Y., Murray, J., Ritchie, L. D., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05992-1 · Cited by 47
Çeli̇k, İ., Erol, M., & Düzgün, Z. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10215-5 · Cited by 49
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?
Zhang, Y., Zhong, Y., Pan, L., & Dong, J. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.03006 · Cited by 46
Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients
Aly, M. H., Rahman, S. S. U., Ahmed, W., Alghamedi, M. H., Shehri, A. A. A., Alkalkami, A. M., & Hassan, M. H. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s261159 · Cited by 46
Metadata
- Authors
- Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R.
- Affiliations
- Wuhan Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Corresponding author
- Zhang, Ruiguang
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-03-16
- Volume
- 71
- Issue
- 15
- Pages
- 769-777
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7184452
- OpenAlex
- W3012492786
- Cited by
- 1,063
- References
- 28
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 32 · 2023: 92 · 2022: 120 · 2021: 288 · 2020: 516
- FWCI
- 33.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- COVID-19 pandemic, SARS-CoV-2, clinical features, mortality, oxygen saturation, comorbidities, inflammatory cytokines, interleukin-6, IL-10, C-reactive protein, lactate dehydrogenase, arbidol, antiviral therapy, hospitalized patients
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Aged, C-Reactive Protein, China, Cough, Female, Fever, Hospitalization, Humans, Male, Middle Aged, Patient Discharge, Pneumonia, Viral, Interleukin-6, Interleukin-10, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
